BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jani M, Ambrus C, Magnan R, Jakab KT, Beéry E, Zolnerciks JK, Krajcsi P. Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics. Arch Toxicol 2014;88:1205-48. [DOI: 10.1007/s00204-014-1224-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Gleich A, Kaiser B, Honscha W, Fuhrmann H, Schoeniger A. Evaluation of the hepatocyte-derived cell line BFH12 as an in vitro model for bovine biotransformation. Cytotechnology 2019;71:231-44. [PMID: 30617848 DOI: 10.1007/s10616-018-0279-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
2 Zappe K, Cichna-Markl M. Aberrant DNA Methylation of ABC Transporters in Cancer. Cells 2020;9:E2281. [PMID: 33066132 DOI: 10.3390/cells9102281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hénin E, Honorat M, Guitton J, Di Pietro A, Payen L, Tod M. Pharmacokinetic interactions in mice between irinotecan and MBL-II-141, an ABCG2 inhibitor. Biopharm Drug Dispos 2017;38:351-62. [PMID: 28207160 DOI: 10.1002/bdd.2069] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Bugde P, Biswas R, Merien F, Lu J, Liu D, Chen M, Zhou S, Li Y. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance. Expert Opinion on Therapeutic Targets 2017;21:511-30. [DOI: 10.1080/14728222.2017.1310841] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 12.6] [Reference Citation Analysis]
5 García-mateos D, García-villalba R, Marañón JA, Espín JC, Merino G, Álvarez AI. The Breast Cancer Resistance Protein (BCRP/ABCG2) influences the levels of enterolignans and their metabolites in plasma, milk and mammary gland. Journal of Functional Foods 2017;35:648-54. [DOI: 10.1016/j.jff.2017.06.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
6 Ferreira RJ, Bonito CA, Cordeiro MNDS, Ferreira MU, Dos Santos DJVA. Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies. Sci Rep 2017;7:15534. [PMID: 29138424 DOI: 10.1038/s41598-017-15452-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
7 Ai N, Fan X, Ekins S. In silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond. Adv Drug Deliv Rev 2015;86:46-60. [PMID: 25796619 DOI: 10.1016/j.addr.2015.03.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
8 Roma MG, Barosso IR, Miszczuk GS, Crocenzi FA, Pozzi EJS. Dynamic Localization of Hepatocellular Transporters: Role in Biliary Excretion and Impairment in Cholestasis. CMC 2019;26:1113-54. [DOI: 10.2174/0929867325666171205153204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Herbrink M, Nuijen B, Schellens JH, Beijnen JH. Variability in bioavailability of small molecular tyrosine kinase inhibitors. Cancer Treat Rev 2015;41:412-22. [PMID: 25818541 DOI: 10.1016/j.ctrv.2015.03.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
10 Wen X, Kozlosky D, Zhang R, Doherty C, Buckley B, Barrett E, Aleksunes LM. BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity. Drug Metab Dispos 2021;49:629-37. [PMID: 34074729 DOI: 10.1124/dmd.121.000446] [Reference Citation Analysis]
11 Walsh DR, Nolin TD, Friedman PA. Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins. Pharmacol Rev 2015;67:656-80. [PMID: 26092975 DOI: 10.1124/pr.115.010728] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
12 Iorio AL, Ros Md, Fantappiè O, Lucchesi M, Facchini L, Stival A, Becciani S, Guidi M, Favre C, Martino Md, Genitori L, Sardi I. Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases. Anticancer Agents Med Chem 2016;16:810-5. [PMID: 26584727 DOI: 10.2174/1871520616666151120121928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
13 Kacirova I, Grundmann M, Brozmanova H. Valproic Acid Concentrations in Mothers, Colostrum and Breastfed Infants during the Early Postpartum Period: Comparison with Concentrations Determined during Delivery and in the Mature Milk Period. Pharmaceutics 2021;13:2074. [PMID: 34959355 DOI: 10.3390/pharmaceutics13122074] [Reference Citation Analysis]
14 Xu R, Yuan Y, Qi J, Zhou J, Guo X, Zhang J, Zhan R. Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model. Evid Based Complement Alternat Med 2018;2018:8340563. [PMID: 30671130 DOI: 10.1155/2018/8340563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
15 Zhou Y, Li H, Xu P, Sun L, Wang Q, Lu Q, Yuan H, Liu Y. Paliperidone, a relatively novel atypical antipsychotic drug, is a substrate for breast cancer resistance protein. Exp Ther Med 2018;16:5410-6. [PMID: 30542502 DOI: 10.3892/etm.2018.6847] [Reference Citation Analysis]
16 Briz O, Perez-Silva L, Al-Abdulla R, Abete L, Reviejo M, Romero MR, Marin JJG. What "The Cancer Genome Atlas" database tells us about the role of ATP-binding cassette (ABC) proteins in chemoresistance to anticancer drugs. Expert Opin Drug Metab Toxicol 2019;15:577-93. [PMID: 31185182 DOI: 10.1080/17425255.2019.1631285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
17 Otero JA, García-Mateos D, de la Fuente A, Prieto JG, Álvarez AI, Merino G. Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin. J Dairy Sci 2016;99:5731-8. [PMID: 27157572 DOI: 10.3168/jds.2015-10593] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 MacLeod AK, Fallon PG, Sharp S, Henderson CJ, Wolf CR, Huang JT. An enhanced in vivo stable isotope labeling by amino acids in cell culture (SILAC) model for quantification of drug metabolism enzymes. Mol Cell Proteomics 2015;14:750-60. [PMID: 25561501 DOI: 10.1074/mcp.M114.043661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
19 Brackman DJ, Giacomini KM. Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response. Clin Pharmacol Ther 2018;103:233-42. [PMID: 29023674 DOI: 10.1002/cpt.903] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
20 Khunweeraphong N, Kuchler K. The first intracellular loop is essential for the catalytic cycle of the human ABCG2 multidrug resistance transporter. FEBS Lett 2020;594:4059-75. [PMID: 33169382 DOI: 10.1002/1873-3468.13994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Puris E, Auriola S, Petralla S, Hartman R, Gynther M, de Lange EC, Fricker G. Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105741] [Reference Citation Analysis]
22 Kumar A, Jaitak V. Natural products as multidrug resistance modulators in cancer. Eur J Med Chem 2019;176:268-91. [PMID: 31103904 DOI: 10.1016/j.ejmech.2019.05.027] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 27.0] [Reference Citation Analysis]
23 Lai Y, Chu X, Di L, Gao W, Guo Y, Liu X, Lu C, Mao J, Shen H, Tang H, Xia CQ, Zhang L, Ding X. Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. Acta Pharmaceutica Sinica B 2022;12:2751-77. [DOI: 10.1016/j.apsb.2022.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sáfár Z, Jani M, Makai I, Fekete Z, Bui A, Molnár É, Pádár P, Pratt JR, Kis E, Beéry E, Krajcsi P. Correlation Analysis of Potential Breast Cancer Resistance Protein Probes in Different Monolayer Systems. Journal of Pharmaceutical Sciences 2018;107:2742-7. [DOI: 10.1016/j.xphs.2018.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Tang Y, Wang Y, Kiani MF, Wang B. Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. Clin Breast Cancer. 2016;16:335-343. [PMID: 27268750 DOI: 10.1016/j.clbc.2016.05.012] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 17.5] [Reference Citation Analysis]
26 Villanueva S, Zhang W, Zecchinati F, Mottino A, Vore M. ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine. Curr Med Chem 2019;26:1155-84. [PMID: 29589524 DOI: 10.2174/0929867325666180327092639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Zhou L, Chen L, Wang Y, Huang J, Yang G, Tan Z, Wang Y, Liao J, Zhou G, Hu K, Li Z, Ouyang D. Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers. J Ginseng Res 2019;43:460-74. [PMID: 31308818 DOI: 10.1016/j.jgr.2018.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Sato S, Matsumiya K, Tohyama K, Kosugi Y. Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios. AAPS J 2021;23:81. [PMID: 34085128 DOI: 10.1208/s12248-021-00609-6] [Reference Citation Analysis]
29 Yang M, Yu C, Chao PL, Lin S, Hou Y. R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies. Journal of Pharmaceutical Sciences 2017;106:1419-25. [DOI: 10.1016/j.xphs.2017.01.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
30 Kunjiappan S, Panneerselvam T, Govindaraj S, Parasuraman P, Baskararaj S, Sankaranarayanan M, Arunachalam S, Babkiewicz E, Jeyakumar A, Lakshmanan M. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment. Anticancer Agents Med Chem 2019;19:1966-82. [PMID: 31267878 DOI: 10.2174/1871520619666190702145609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
31 Makrides V, Dolgodilina E, Virgintino D. Blood–Brain Barrier Transporters and Neuroinflammation: Partners in Neuroprotection and in Pathology. In: Lyck R, Enzmann G, editors. The Blood Brain Barrier and Inflammation. Cham: Springer International Publishing; 2017. pp. 103-51. [DOI: 10.1007/978-3-319-45514-3_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers (Basel) 2019;11:E407. [PMID: 30909445 DOI: 10.3390/cancers11030407] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
33 Fardel O, Le Vee M, Jouan E, Denizot C, Parmentier Y. Nature and uses of fluorescent dyes for drug transporter studies. Expert Opin Drug Metab Toxicol 2015;11:1233-51. [PMID: 26050735 DOI: 10.1517/17425255.2015.1053462] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
34 Chedik L, Bruyere A, Bacle A, Potin S, Le Vée M, Fardel O. Interactions of pesticides with membrane drug transporters: implications for toxicokinetics and toxicity. Expert Opinion on Drug Metabolism & Toxicology 2018;14:739-52. [DOI: 10.1080/17425255.2018.1487398] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
35 Hermann R, Krajcsi P, Fluck M, Seithel-Keuth A, Bytyqi A, Galazka A, Munafo A. Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine. Clin Pharmacokinet 2021. [PMID: 34435310 DOI: 10.1007/s40262-021-01065-3] [Reference Citation Analysis]
36 Słomka M, Sobalska-Kwapis M, Korycka-Machała M, Dziadek J, Bartosz G, Strapagiel D. Comprehensive Analysis of ABCG2 Genetic Variation in the Polish Population and Its Inter-Population Comparison. Genes (Basel) 2020;11:E1144. [PMID: 33003314 DOI: 10.3390/genes11101144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Li N, Sui Z, Liu Y, Wang D, Ge G, Yang L. A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix. RSC Adv 2018;8:34514-24. [DOI: 10.1039/c8ra05992f] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Gupta SK, Singh P, Ali V, Verma M. Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncol Rev 2020;14:448. [PMID: 32676170 DOI: 10.4081/oncol.2020.448] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zhang GN, Zhang YK, Wang YJ, Barbuti AM, Zhu XJ, Yu XY, Wen AW, Wurpel JND, Chen ZS. Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib. Pharmacol Res 2017;119:89-98. [PMID: 28131876 DOI: 10.1016/j.phrs.2017.01.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
40 Szilagyi JT, Vetrano AM, Laskin JD, Aleksunes LM. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity. Placenta 2017;55:29-36. [PMID: 28623970 DOI: 10.1016/j.placenta.2017.04.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
41 Bhardwaj B, Baidya ATK, Amin SA, Adhikari N, Jha T, Gayen S. Insight into structural features of phenyltetrazole derivatives as ABCG2 inhibitors for the treatment of multidrug resistance in cancer. SAR QSAR Environ Res 2019;30:457-75. [PMID: 31157558 DOI: 10.1080/1062936X.2019.1615545] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
42 Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, Li J. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016;370:153-164. [PMID: 26499806 DOI: 10.1016/j.canlet.2015.10.010] [Cited by in Crossref: 379] [Cited by in F6Publishing: 368] [Article Influence: 54.1] [Reference Citation Analysis]
43 Xu Y, Egido E, Li-Blatter X, Müller R, Merino G, Bernèche S, Seelig A. Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1). Biochemistry 2015;54:6195-206. [PMID: 26381710 DOI: 10.1021/acs.biochem.5b00649] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
44 García-Lino AM, Álvarez-Fernández I, Blanco-Paniagua E, Merino G, Álvarez AI. Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk. Nutrients 2019;11:E2372. [PMID: 31590349 DOI: 10.3390/nu11102372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
45 Joshi P, Patel R, Kang SY, Serbinowski E, Lee MY. Establishment of ion channel and ABC transporter assays in 3D-cultured ReNcell VM on a 384-pillar plate for neurotoxicity potential. Toxicol In Vitro 2022;:105375. [PMID: 35550413 DOI: 10.1016/j.tiv.2022.105375] [Reference Citation Analysis]
46 Katagiri Y, Kawaguchi H, Umemura K, Tadano J, Miyawaki I, Takano M. Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in rats. Drug Metab Pharmacokinet 2021;42:100430. [PMID: 34896751 DOI: 10.1016/j.dmpk.2021.100430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Safar Z, Kis E, Erdo F, Zolnerciks JK, Krajcsi P. ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors. Expert Opin Drug Metab Toxicol 2019;15:313-28. [PMID: 30856014 DOI: 10.1080/17425255.2019.1591373] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
48 El-sheikh AAK, Morsy MA, Al-taher AY. Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve BCRP/ABCG2. Fundam Clin Pharmacol 2016;30:406-18. [DOI: 10.1111/fcp.12205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]